-
Study aim
-
Determining the effects of propolis supplementation on sperm parameters, oxidative stress , sperm DNA fragmentation and HOTAIR LncRNA expression in infertile men with asthenozoospermia.
-
Design
-
Clinical trial with control group, parallel, double-blind, randomized block method on 60 patients.
-
Settings and conduct
-
Patients referring to the infertility clinic of Imam Khomeini Hospital in Ahvaz, after being diagnosed by a specialist doctor, will be included in the study if they have informed consent and meet the inclusion criteria. Patients are randomly divided into two groups receiving propolis and placebo. Participants and evaluators and researchers do not know which group they are in
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria; Willingness to participate in the study At least one year passed since the decision to have children and not using contraceptives Age 20 to 50 years suffering from asthenozoospermia with total sperm motility less than 40% in the semen sample of unknown origin. Exclusion criteria; The presence of a known cause of infertility (hormonal disorders, epididymal duct obstruction and epididymovarcitis), Drug abuse ,Alcohol use Having a chronic disease (diabetes, kidney disease, chronic liver disease), Varicocele, Infectious diseases characterized by fever and leukocytosis. body mass index (BMI) higher than 30 and less than 18.5 kg/m2
-
Intervention groups
-
Patients are randomly divided into two groups(propolis or placebo). The propolis group will be given propolis capsules (500 mg 3 times a day) and the placebo group will be given placebo capsules.
-
Main outcome variables
-
Semen parameters, oxidative stress , sperm DNA fragmentation and (HOX antisense intergenic RNA) LncRNA ( (HOTAIR)expression